Rauwerdink, Daan Jan Willem
Molina, George
Frederick, Dennie Tompers
Sharova, Tanya
van der Hage, Jos
Cohen, Sonia
Boland, Genevieve Marie
Article History
Received: 29 March 2020
First Online: 29 May 2020
Disclosures
: Dr. Genevieve Boland reports sponsored research agreements with Takeda Oncology, Olink Proteomics, and Palleon Pharmaceuticals, but these are outside the current work under consideration. She also served as a speaker for Takeda Oncology and Novartis, none of which are in conflict with the manuscript under review. She also served on a scientific advisory board and is on a steering committee with Nektar Therapeutics, again none of which is related to the work submitted. All other authors report no conflicts of interest.